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We report an investigation of peripheral blood mono-
cytes from untreated patients with mild, quiescent pso-
riasis. Possible metabolic changes were monitored by 
the determination of 3 enzymes representing different 
pathways of glucose metabolism and 2 lysosomal en-
zymes. Signal processing was evaluated by the measure-
ment of cyclic AMP levels before and after hormonal 
stimulation. Luminol-amplified chemiluminescence pro-
vided an objective approach to assessing phagocytic ca-
pacity. Finally, the pattern of maturation of normal and 
psoriatic monocytes has been compared during culture 
in vitro. 
Our results were uniformly and wholly negative; we 
conclude that the concept of an "intrinsic" abnormality 
of the psoriatic monocyte may be excluded. Possible 
reasons for discrepancies in the literature are discussed. 
During the last decade a number of publications have ap-
peared concerning metabolic or functional aspects of circulating 
leukocytes in patients with psoriasis. Changes have been re-
ported in various purified or partially purified preparations, 
including granulocytes, monocytes, lymphocytes, and mixed 
mononuclear leukocytes (MNL). Unfortunately, the various 
authors are hy no means in agreement in their conclusions; 
claims have included specific abormalities apparently charac-
teristic of t he psoriatic genotype, various "secondary" a ltera-
t ions (i.e., changes paralleling disease activity), an d, occasion-
ally, entirely negative findings. The field has recently been the 
subject of a comprehensive and balanced review [1]. 
This uncertainty is particularly frustrating in the case of the 
monocyte/macrophage cell line. It has already been pointed out 
that an int rins ic fault in the psoriatic monocyte is compatible 
with the breakdown of epidermal homeostasis which occurs in 
t he skin lesion [2); it is thus of paramount importance to 
establish whether such an abnormality really exists. We have 
therefore undertaken a detai led investigation of this cell in 
psoriasis. Measurements have been made at various levels, 
including metabolic (3 enzymes of intermediary metabolism 
and 2 acid hydrolases), signal processing (cyc ~ic AMP), phago-
cytic abi li ty (chemiluminescence), and certam parameters of 
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ACP: acid phosphatase 
G-6-PDH: glucose-6-phosphate dehydrogenase 
GBSS: Gey's balanced salt solu tion without phenol red contai ning 
0.2% bovine serum albumin 
lCD: isocitrate dehydrogenase 
MNL: mononuclear leukocytes 
NAG: N-acetylglucosaminidase 
PBSA: phosphate-buffered saline containing 0.2% human albu -
min 
PBST: phosphate-buffered saline contain ing 5 mM MgCI" and 7.5 
mM theophylline 
PG: prostaglandin 
PHI: phosphohexose isomerase 
maturation in vitro . Throughout the investigation extreme care 
has been taken to avoid artifacts arising from environmental 
circumstances such as hospitalization or therapy, and to e lim-
inate temporal "drift" by the use of paired subjects rather than 
independent groups. Our ftndings are presented below. 
MATERIALS AND METHODS 
Materials 
Heparin was obtained from Diosynth BY, Oss, NL, and Ficoll-Paque 
from Pharmacia, Uppsala, Sweden. All materials for tissue culture were 
supplied by Gibco Europe BY, Hoofddorp, NL. Luminol and zymosan 
were purchased from the Sigma Chemical Co, St. Louis, Missouri· 
enzyme substrates were supplied either by Sigma or Boehringe; 
Mannheim BY, Amsterdam. Diamidino-2-phenylindole was obtained 
from Serva Feinbiochemica GmbH, Heidelberg, FRG, adrenaline from 
Centra Chemie BY, Etten-Leur, NL. Reagents for the measurement of 
cyclic AMP were supplied by New England Nuclear, Doorn, NL. Bovine 
serum albumin was purchased from Organon BY, Oss, NL and human 
serum albumin from the Jnst.itut Merieux SA, Lyon, France. 
All other chemicals were of the highest purity available and were 
supplied by Merck (Darmstadt, FRG). 
Subjects 
Most of the patients taking part in t his study were drawn from the 
Association of Psoriatic Patients of the Netherlands (Nederlandse 
Yereniging voor Psoriasis Patienten); these patients in general had 
relatively mild plaque type lesions. A few pat ients were referred from 
the Dermatology Department of th is hospital; this group had more 
extensive lesions. None of either group had received systemic therapy 
in the year prior to investigation, and none had received therapy of 
any kind for at least 2 months. Control subjects were paid volunteers 
with no personal or fami ly history of psoriasis. Relevant data for the 
psoriatic and control groups are summarized in Table I; some subjects 
participated in more than one set of measurements. 
Isolation and Identification of Cells 
Blood (5- 40 ml) was obtained by venepuncture and heparin (10 IU 
per ml) added as anticoagu lant. MNL were isolated by isopycnic 
centrifugation on Ficoll-Hypaque 13] followed by 3 washings wi t h 
phosphate-buffered saline containing 0.2% hu man album in (PBSA). 
This preparation was either used directly (chemiluminesce nce) or fur-
ther fractionated by counterllow centrifugation [3] (cyclic AMP, en-
zyme measurements, culture experiments). 
Total cell counts were performed using a Coulter counter (model 
DN) or hemocytometer. Differentiation of ce ll types utilized either 
May-Grunwald-Giemsa or nonspecific esterase staining of cytocentri-
fuge preparations. 
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Culture Technique 
This was described previously. In brief, isolated monocytes were 
resuspended in RPM! 1640 medium (enriched with 10% autologous 
serum) at a density of approximately 3 X 10'' ce lls/ml, and 1-ml portions 
dispensed into Costar Leighton cultu re tubes (5-cm' culture surface ). 
The monocytes were allowed to mature at 37"C for the following 2 
weeks. 
Enzyme and DNA Measurement 
These procedures have already been desc ribed in full [4]. Cells were 
lysed in a solu tion of bovine serum albumin in water (I mg per ml) 
using either one cycle of freeze-thawing followed by sonication (fresh 
monocytes) or 3 cycles of freeze-thaw ing (cu ltured monocytes). After 
centrifugation, the activities of 5 enzymes were determined using 
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TABLE I. Composition of experimental groups; data for controls in 
parenthesis 
in vestigation No. M/ F Age Years Percentage p o rins is lesions 
Enzyme 9 4/5 42 ± 17 17 ± 16 8±6 
measurements (12) (10/2) (30 ± 5) 
Cyclic AMP 9 4/ 5 42 ± 16 22 ± 15 10 ± 4 
(9) (8/1) (29 ± 5) 
Chemilumines- 19 7/12 43 ± 17 20 ± 16 10 ± 13 
cence (19) (13/6) (32 ± 11) 
duplicate 20- 111 samples of the appropriately diluted supernatant. In 
brief, glucose-6-phosphate dehydrogenase (G -6- PDH ), phosphohexose 
isomerase (PHI), and isocitrate dehydrogenase (lCD) were measured 
by the f1uorescence of NADPH released during NADP-linked assays; 
acid phosphatase (ACP) and N-acetylglucosaminidase (NAG) were 
determ ined by the fluorescence of 4-methylu mbelliferone released from 
the appropriate substrates. In all cases reaction rates were shown to be 
proportional to the concentration of cell lysate at the dilution employed. 
The DNA contents of t he supernatants were measured by fluores-
cence of the complex with 4' ,6-diamidino-2-phenylindole [5) using a 
modification described previously [6]. 
Cyclic AMP Measurements 
Freshly- isolated monocytes were resuspended in phosphate-bufJered 
saline contain ing 5 mM MgC}z and 7.5 mM theophylline (PBST) at a 
density of 4 x 10~; cells per mi. After 20-min preincubation at 37•c, an 
aliquot of 100 ILl was "f1ash-heated" (2 min, 1oo•c) and acidified with 
50 ILl of 0.1 N HCI. Two additional aliquots of 25 J.d were mixed with 
75 ILl of adrenali ne or prostaglandin E1 (PGE 1) in PBST (final concen-
trations of 100 ILM and 10 11M, respectively) . Afte r a 5-min further 
incubation these were flash-heated and acidified as before. All samples 
were centrifuged and duplicate 50-I' ! aliquots of the supernatants taken 
fo r assay of cyclic AMP. 
Cyclic AMP was measured by radioimmunoassay followin g acetyla-
t ion. The reagents employed gave linearity over the range 10- 500 fmol 
per assay. Serial dilut ion of a single pooled extract plus a parallel 
"spiked" series indicated a recovery of better than 90% and a repro-
ducibili ty of± 15%. Agreement between duplicates was usually better 
t han 10%; samples where this was not achieved were disrega rded. 
Chemiluminescence 
The washed MNL pellet. was resuspended in Gey's balanced salt 
solu tion without phenol red containing 0.2% bovine serum albumin 
(GBSS) at a concentration of about 5 x 106 cells per mi. Duplicate 200-
J.Ll a liquots were placed in 4- ml clear glass tubes, and 200 ILl of luminal 
(250 J.Lg/ ml in GBSS, freshly dilu ted from a stoc k of 25 mg/ml in 
dimethyl sulfoxide) was added. After a 10-min preincubation at 37•c 
t he ligh t emission was measured using a modified Locarte fluorimeter 
(light source "off," sensitivity controls maximum) . A 200-11! aliquot of 
opsonized zymozan (1 mg/ml in GBSS, opsonized as described previ-
ously [7)) was added to each tube, and the mixture incubated at 37•c . 
L ight emission was determined at 5-min intervals during the following 
30 min. 
Light output was shown to be proportional to cell density up to at 
least 2.5 x 107 cells/ml (i.e., 5 X 106 cells per assay). T he instrument 
was cal ibrated daily using a standard light source of 25 ILCi :JH in 
sci ntillation fluid; this gave approx imately 75% full-scale deflection 
(i.e., 750 empirical units) and did not vary by more than ± 5% during 
t he course of the experiments. 
Statistics 
Nonparametric methods (Wilcoxon ranking test ) were employed 
t hroughout for evaluation or levels or significance. 
RESULTS 
General 
No diffe rences were observed between monocytes from pso-
riatic pati ents and those from controls in a bsolute numbe rs , in 
morphology, or in t he ir behavior during fractionation. Thus the 
percentage monocytes in cytocentrifuge preparations of MNL 
was 27 ± 5 for co nt rols and 29 ± 6 for patien ts. Coun terflow 
centrifugatio n of MNL suspe ns ions gave monocyte fractions of 
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88 ± 3% purity, 79 ± 7% relative yield for cont rols a nd 90 ± 
2% purity, 76 ± 14 % relative y ield for patients. Behavior during 
culture was again identica l, both controls a nd patients s howing 
s imila r morphologic cha nges and percentage cell losses during 
2 weeks in culture . 
Enzyme Studies: Fresh Monocytes 
The levels of 5 enzymes in fresh ly isolated monocytes from 
9 paired subjects plus 3 additiona l cont rols a re illustrated in 
Fig 1. Nonparametric statistical analysis shows no s ign ificant 
diffe rence betwee n normal a nd psoriatic subjects at t he level p 
= 0.05 for any enzyme; t his holds t rue using either t he pa ired 
subjects a lone (2-tai\ed test) or a na lysis as independent groups 
of 12 a nd 9 subjects (1-tai led test). 
Cyclic AMP Levels 
"Resting," adrena line-stimulated, a nd PGE1-stimulated 
cyclic AMP levels in fresh ly isolated monocytes from 9 paired 
subjects a re s hown in Table II. Again , no differences can be 
shown at the level p = 0.05. It should be noted t hat a total of 3 
values has been omitted from Table II because of poor agree-
men t between t he duplicate samples; inclus ion of t hese figures 
(not s hown) does not a lter t hi s negative conclusion . Alternative 
statistical approaches (for exa mple, analysis of percentage in-
creases of cyclic AMP following stimulation) a lso failed to y ield 
any s ignifica n t di fference between psoriatic a nd control sub-
jects . 
Chemiluminescence 
Table Ill (column 2) summarizes the peak chemilumines-
cence, expressed in terms of t he total MNL population , for 19 
con t rol- psoriat ic pairs . In 13 of t hese pairs t he percentage of 
monocytes was dete rmined by count ing stained cytocentrifuge 
preparations, and t he data for these have been recalculated in 
te rms of mo nocytes only (column 3). In neit her case does t he 
diffe rence between co ntrol and psoriat ic subjects reach the 
s ignifican ce level of p = 0.05. 
The t ime curves for light output following t he addit ion of 
opsonized zymosan (based on mon ocyte counts and averaged 
for 13 pa irs) are illustrated in Fig 2. It is seen that the ti me 
course of events is s imilar for con t rols and psoria t ics. 
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FIG 1. Activities of 5 enzymes in freshly iso lated blood monocytes 
from normal co ntrols (open circles) and pso riatic patients (filled circles) . 
TABLE IT. Cyclic AMP leveL~ (pmol per 10" monocytes. mean± SDJ 
before and after hormonal stimulation 
Subjects 
Controls 
Psoriatic 
Cyclic AMP 
Re>;ting + Adrena line + PGE, 
4.7 ± 4.0 (n= 9) 10.7 ± 8.3 (n= 9) 39.4 ± 26.9 (n = 9) 
4.5 ± 4.9 (n=9) lG.O ± 10.7 (n=7) 35. 1 ± 18.3 (n=S) 
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Maturation in Culture 
Four sets of cultures were set up from control subjects and 
two from psoriatic patients. Maturation was assessed by the 
levels of activity of the enzymes described for fresh monocytes, 
since it has already been established that certain of these (G-
6-PDH, NAG, ACP) increase dramatically during t he differ-
entiation of monocytes to macrophages [14] . These results are 
summarized in Fig 3. Although the numbers are too small to 
permit statistical analysis, it is clear that the time course of 
maturation of the psoriatic cells (at least in terms of metabolic 
parameters) is indistinguishable from normaL 
DISCUSSION 
Cellular processes such as surface attachment, chemotaxis 
and phagocytosis are in general mediated by changes in cyclic 
nucleotide levels, which in turn trigger the alterations in met-
aboli c activity necessary to support such functions. Thus it is 
TABLE IlL Peak. chemiluminescence leveL~ (arbitrary units, mean± 
SD) following phagocytosis of opsonized zymosan 
Subjects 
Controls 
Psoriatic 
Chemiluminescence 
per 106 MNL 
266 ± 122 (n=19) 
313 ± 139 (n=l9) 
per 106 Monocytes 
1054 ± 382 (n=13) 
1143 ± 431 (n=13) 
C h ernc lurnlne s c e n ce -----------------~ 
1500 
A ddi ti o n o f 
. 1000 
500 
10 20 30 40 
T ime (rn in) 
F1c. 2. Time course of monocyte chemiluminescence. Opsonized 
zymosan was added immediately after the 10-min reading. Open. circles 
represent heal thy controls, filled circles psoriatic patients. Mean of 13 
pairs± SEM. 
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unlikely that a "faul t" could be manifest at one level of or-
ganization alone. 
In the present investigation we have selected various param-
eters representing a ll three levels of organization; the individual 
measurements have been chosen on the basis of sensitiv ity 
(multiple assays using a n acceptable blood sample), simplicity 
and proven reliabili ty. The agreement among independent ex~ 
perimental data at each level therefore greatly strengthens our 
overall conclusions, namely that we may exclude t he concept 
of a primary abnormality in the psoriatic monocyte. 
An overview of previous reports regarding metabolic activity 
cyclic AMP levels, and chemiluminescence following phagocy~ 
tosis is presented in Table IV; other studies of monocyte 
function in psoriasis are discussed by Krueger [1]. Clearly, an 
attempt must be made to explain the discrepancies between 
our present findings and the earlier literature . Three aspects 
will be considered here. 
First, it must be emphasized that our patients were almost 
all in a quiescent phase of the disease, and that most had 
minimal lesions. Thus our findings do not rule out the possi-
bility of secondary changes in patients with act ive or extensive 
psoriasis, and are not necessarily in conf1ict with studies em-
ploying such subjects [9]. In act ive psoriasis, as in other inflam-
matory processes (for example infections), monocytopoietic 
hyperproliferation occurs, probably reflecting increased mono-
cyte consumption by the pathologic processes. This results 
inevitably in premature monocyte release from the bone mar-
row [15]; clearly, these relatively young monocytes may differ 
in many respects from the more mature cells. 
Second, the possible effects of therapy must be considered. 
Rela t ive enzyrne a c t iv ity ------ - - -----------
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FIG 3. Changes in enzyme activity during cultivation of monocytes 
in vitro. The value on day 0 (freshly isolated monocytes) is designated 
as unity. 
TABLE IV. Summary of relevant literature 
Measurement 
Metabolic 
Cyclic AMP 
Ref 
8 
9 
10 
11 
9 
Chemiluminescence 12 
13 
Cell 
type 
MNL 
Mo 
MNL 
Mo 
Mo 
MNL 
Extent of 
disease 
Variable 
>25% 
Variable 
Variable 
>25% 
5--20% 
Mo = monocytes; NBT = nitro blue tetrazolium; HMPS 
cytotoxicity; PMA = phorbol myristate acetate. 
Therapy 
None for 2 
weeks 
Topical steroids 
and/or tar 
Topical 
Topical steroids 
and/or tar 
Topical steroids 
and/or tar 
Conclusions 
Increased NBT reduction, seve ri ty-related 
Resting HMPS activity normal; increased response to 
ADCC; lysosyme release during ADCC normal; su-
peroxide production following PMA normal 
Resting and stimulated levels both slightly decreased 
Resting and stimulated levels normal 
Normal during ADCC 
Faster response and increased peak values following 
zymosan phagocytosis 
Anthralin Increased values following zymosan 
hexose monophosphate shunt; ADCC = antibody-dependent cell -mediated 
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It is extremely difficult, via a hospital system, to locate patients 
who really have received no therapy of any kind for a long 
period. Most workers therefore opt either for "topical t herapy 
only" [9- 11, 13) or withhold treatment for an a rbitrary (usually 
short) period (8]. Here we have overcome t his problem by 
locating psoriatic subjects via a nonmedical organ ization (As-
sociation of Psoriatic Patients), many of whose members are 
routinely untreated. 
Finally, we would point out the extreme labi lity of certain 
blood leukocyte parameters, an observation that has received 
comparatively li ttle attention in the li tera ture. For example, 
cyclic AMP levels fa ll to 5- 30% of their original values after 2 
h [16] ; similar declines in chemiluminescence have been ob-
served [C. Figdor , personal communication]. Thus t rivia l vari-
ations in processing t ime may produce substantial variation in 
observed data, and any systemic differences among groups 
(such as transport of spec imens from clinic to laboratory) may 
result in highly "significant" findings. In the present investi-
gation, the use of t ime-matched patient- control pairs has cir-
cumvented t his problem. 
There has been considerable argume nt over the past decade 
as to whether the systemic immunologic disturbances in pso-
riasis are of etiologic sign ificance or are secondary to the 
cutaneous lesions. Our present findings, although throwing no 
direct light on the pathogenesis of psoriasis, at least offer strong 
evidence in favor of the latter view. 
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